AAAAAA
Results:
1-14
|
Results: 14
Authors:
Weissfloch, L
Wagner, M
Probst, T
Senekowitsch-Schmidtke, R
Tempel, K
Molls, M
Citation: L. Weissfloch et al., A new Class of Drugs for BNCT? Borylated derivatives of ferrocenium compounds in animal experiments, BIOMETALS, 14(1), 2001, pp. 43-49
Authors:
Matsunari, I
Haas, F
Nguyen, NTB
Reidel, G
Wolf, I
Senekowitsch-Schmidtke, R
Stocklin, G
Schwaiger, M
Citation: I. Matsunari et al., Comparison of sestamibi, tetrofosmin, and Q12 retention in porcine myocardium, J NUCL MED, 42(5), 2001, pp. 818-823
Authors:
Haubner, R
Wester, HJ
Burkhart, F
Senekowitsch-Schmidtke, R
Weber, W
Goodman, SL
Kessler, H
Schwaiger, M
Citation: R. Haubner et al., Glycosylated RGD-containing peptides, tracer for tumor targeting and angiogenesis imaging with improved biokinetics, J NUCL MED, 42(2), 2001, pp. 326-336
Authors:
Senekowitsch-Schmidtke, R
Schuhmacher, C
Becker, KF
Nikula, TK
Seidl, C
Becker, I
Miederer, M
Apostolidis, C
Adam, C
Huber, R
Kremmer, E
Fischer, K
Schwaiger, M
Citation: R. Senekowitsch-schmidtke et al., Highly specific tumor binding of a Bi-213-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer, CANCER RES, 61(7), 2001, pp. 2804-2808
Authors:
Haubner, R
Wester, HJ
Weber, WA
Mang, C
Ziegler, SI
Goodman, SL
Senekowitsch-Schmidtke, R
Kessler, H
Schwaiger, M
Citation: R. Haubner et al., Noninvasive imaging of alpha(v)beta(3) integrin expression using F-18-labeled RGD-containing glycopeptide and positron emission tomography, CANCER RES, 61(5), 2001, pp. 1781-1785
Authors:
Ercan, MT
Senekowitsch-Schmidtke, R
Bernatz, S
Citation: Mt. Ercan et al., Biodistribution of Tc-99m-glutathione in mice with osteosarcoma: effect ofgamma irradiation on tumour uptake, RES EXP MED, 199(6), 2000, pp. 359-367
Authors:
Wester, HJ
Herz, M
Senekowitsch-Schmidtke, R
Schwaiger, M
Stocklin, G
Hamacher, K
Citation: Hj. Wester et al., Preclinical evaluation of 4-[F-18]fluoroprolines: Diastereomeric effect onmetabolism and uptake in mice, NUCL MED BI, 26(3), 1999, pp. 259-265
Authors:
Langhammer, HR
Laubenbacher, C
Hirsch, C
Klingele, C
Spyra, JL
Senekowitsch-Schmidtke, R
Schwaiger, M
Citation: Hr. Langhammer et al., Radioiodine therapy of autonomous thyroid tissue. Results with respect to pretherapeutic scintigraphic pattern and early response of triiodothyroninelevels, MED KLIN, 94(8), 1999, pp. 415-424
Authors:
Senekowitsch-Schmidtke, R
Citation: R. Senekowitsch-schmidtke, Binding of EGF peptide and EGF receptor antibodies and its fragments in different tumor models, HYBRIDOMA, 18(1), 1999, pp. 29-35
Authors:
Weissfloch, L
Bremer, M
Lemmen, P
Probst, T
Wagner, M
Peller, M
Auberger, T
Senekowitsch-Schmidtke, R
Tempel, K
Molls, M
Citation: L. Weissfloch et al., New drugs for BNCT: An experimental approach, STRAH ONKOL, 175, 1999, pp. 118-120
Authors:
Heiss, P
Mayer, A
Herz, M
Wester, HJ
Schwaiger, M
Senekowitsch-Schmidtke, R
Citation: P. Heiss et al., Investigation of transport mechanism and uptake kinetics of O-(2-[F-18]fluoroethyl)-L-tyrosine in vitro and in vivo, J NUCL MED, 40(8), 1999, pp. 1367-1373
Authors:
Haubner, R
Wester, HJ
Reuning, U
Senekowitsch-Schmidtke, R
Diefenbach, B
Kessler, H
Stocklin, G
Schwaiger, M
Citation: R. Haubner et al., Radiolabeled alpha(v)beta(3) integrin antagonists: A new class of tracers for tumor targeting, J NUCL MED, 40(6), 1999, pp. 1061-1071
Radiolabeled thymidine: A sensitive tracer for early tumor response and recurrence after irradiation
Authors:
Senekowitsch-Schmidtke, R
Ruth, F
Bernatz, S
Citation: R. Senekowitsch-schmidtke et al., Radiolabeled thymidine: A sensitive tracer for early tumor response and recurrence after irradiation, J NUCL MED, 40(10), 1999, pp. 1702-1705
Authors:
Wester, HJ
Herz, M
Weber, W
Heiss, P
Senekowitsch-Schmidtke, R
Schwaiger, M
Stocklin, G
Citation: Hj. Wester et al., Synthesis and radiopharmacology of O-(2-[F-18]fluoroethyl)-L-tyrosine for tumor imaging, J NUCL MED, 40(1), 1999, pp. 205-212
Risultati:
1-14
|